CClinicalTrials.gg
Not yet recruitingNCT07250932Updated Nov 26, 2025

Exploring the Effectiveness of Somatosensory Cognitive Game Intervention on Cognitive and Physical Functions

An interventional study of somatosensory cognitive game in Cognitive Function, sponsored by Taipei Medical University. Not yet recruiting. Open to participants aged 65 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-26.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
65 Years to 100 Years
Sex
All
01

Study summary

This study investigates the effects of somatosensory cognitive games interventions on older adults' cognitive and physical functions. The investigators plan to recruit up to 100 participants and randomly assign them to a control group or an experimental group. The experimental group will participate in somatosensory cognitive games for 12 weeks, while the control group will receive routine care. Data will be collected via questionnaires to examine whether somatosensory cognitive games can delay declines in cognitive and physical functions in older adults.

Read the detailed description

This study investigates the effects of somatosensory cognitive games interventions on the cognitive and physical functions of older adults. The investigators plan to recruit 80 participants and randomly assign them to either a control group or an experimental group. The experimental group will participate in somatosensory cognitive games for 12 weeks, twice a week, about 30 minutes per session; the control group will receive usual care without any specific intervention. All participants will complete four questionnaire assessments to examine whether somatosensory cognitive games can slow decline in cognitive and physical functions.

02

Conditions studied

  • Cognitive Function
03

In context

Lead sponsor

Taipei Medical University is the lead sponsor of 245 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Elderly individuals aged 65 and above.
  2. Able to communicate in Chinese (Mandarin or Taiwanese).
  3. Voluntarily participate in this study and sign a written consent form.

Exclusion criteria

Exclusion Criteria:

  1. Individuals with severe visual impairments or physical mobility disabilities that prevent them from participating in the game activities designed in this study.
  2. Individuals diagnosed with severe dementia who are unable to understand or participate in the research process.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Somatosensory Cognitive Game Intervention on Cognitive and Physical

    Other: somatosensory cognitive game

  • No intervention
    Routine care

    no Intervention on Cognitive and Physical

Interventions

  • Othersomatosensory cognitive game

    The experimental group will participate in somatosensory cognitive games for 12 weeks, twice a week, about 30 minutes per session.

06

What researchers measure

Primary outcomes

  1. Montreal Cognitive Assessment (MoCA)

    MoCA is one of the key cognitive function outcomes that investigators expect to improve after somatosensory cognitive games. MoCA assesses six cognitive dimensions, with a total score of 30. A score of 26 or higher is considered normal. MoCA score of ≤24 may indicate a risk of mild cognitive impairment (MCI), while a MoCA score of ≤20 may indicate a risk of dementia.

    Time frame: 3 month follow-up

  2. Color Trails Test (CTT)

    CTT is one of the key cognitive function outcomes that investigators expect to improve after somatosensory cognitive games. CTT is widely used to assess executive function and processing speed. The first part (CTT-1) evaluates visual-motor skills and attention, while the second part of the CTT (CTT-2) assesses sequencing and cognitive flexibility. Scoring is based on the time required to complete the test, with cutoff times of 240 seconds for CTT-1 and 330 seconds for CTT-2. Shorter completion times indicate better executive function and processing speed.

    Time frame: 3 month follow-up

Secondary outcomes

  1. Short Physical Performance Battery (SPPB)

    SPPB is another secondary outcome measure that researchers expect to improve after intervention with somatosensory cognitive games. SPPB is mainly used to assess the physical function and mobility of elderly people, with a total score range of 0-12 points, where higher scores indicate better physical function.

    Time frame: 3 month follow-up

  2. Timed Up and Go Test (TUG)

    TUG is another secondary outcome measure that researchers expect to improve after intervention with somatosensory cognitive games. TUG is an assessment tool for evaluating gait and mobility in elderly people. TUG \< 10 seconds indicates normal mobility, TUG 11-20 seconds indicates those who can walk independently (but move more slowly), and TUG \> 20 seconds indicates those who require assistive devices (such as walkers).

    Time frame: 3 month follow-up

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07250932
Lead sponsor
Taipei Medical University
Responsible party
Sponsor
First posted
Nov 26, 2025
Start date
Nov 2025 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 26, 2025

Study contacts

Dorothy Bai, PhD
Contact
dbai@tmu.edu.tw
+886-2-27361661 Ext. 6332

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion